TY  - RPRT
TI  - Evolving Role of Immunotherapy in Advanced Esophageal Squamous Cell Carcinoma: Are Programmed Death-Ligand 1 (PD-L1) Cutoffs Still Relevant?
AU  - Praloy Basu
PY  - 2026
DO  - 10.7759/cureus.114584
UR  - https://pubmed.ncbi.nlm.nih.gov/42746208/
ID  - 42746208
ER  -